Send the following on WhatsApp
Continue to Chat雲頂新耀宣佈拓達維® (Trodelvy®)在中國獲批用於轉移性三陰性乳腺癌的二線治療 https://geneonline.news/%e9%9b%b2%e9%a0%82%e6%96%b0%e8%80%80%e5%ae%a3%e4%bd%88%e6%8b%93%e9%81%94%e7%b6%ad-trodelvy%e5%9c%a8%e4%b8%ad%e5%9c%8b%e7%8d%b2%e6%89%b9%e7%94%a8%e6%96%bc%e8%bd%89%e7%a7%bb%e6%80%a7/